Cyclosporine A in the Treatment of Psoriasis: A Clinical and Mechanistic Perspective
- 1 November 1990
- journal article
- review article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 95 (5), S53-S55
- https://doi.org/10.1111/1523-1747.ep12505786
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Intralesional cyclosporine in the treatment of psoriasis: A clinical, immunologic, and pharmacokinetic studyJournal of the American Academy of Dermatology, 1990
- Cyclosporine in dermatologyJournal of the American Academy of Dermatology, 1989
- Long-term cyclosporin for psoriasisBritish Journal of Dermatology, 1989
- Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilinNature, 1989
- INTRALESIONAL INJECTION OF CYCLOSPORIN IN PSORIASISThe Lancet, 1988
- The pathomechanisms of psoriasis; the skin immune system and cyclosporinBritish Journal of Dermatology, 1988
- The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasisBritish Journal of Dermatology, 1987
- Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytesImmunology Today, 1986
- Cyclosporin a for PsoriasisNew England Journal of Medicine, 1979
- Biological effects of cyclosporin A: A new antilymphocytic agentInflammation Research, 1976